Welcome to our dedicated page for AI / ML Innovations news (Ticker: AIMLF), a resource for investors and traders seeking the latest updates and insights on AI / ML Innovations stock.
AI/ML Innovations Inc. develops artificial intelligence and neural-network technology for digital health applications. The company’s platforms use signal processing and deep learning to convert biometric data into clinical insights, with recurring updates centered on ECG analysis, heart rate variability analytics, remote cardiac monitoring, and cardiovascular research support.
News for AIMLF also covers activity at its Neural Cloud Solutions subsidiary, including MaxYield™, CardioYield™, and Insight 360™ commercialization, reseller and distribution agreements, research-services collaborations, medical advisory board appointments, and capital-structure actions such as private placements, convertible debentures, warrants, options, and share issuances for debt settlement.
AI/ML Innovations Inc. (CSE:AIML, OTCQB:AIMLF) announced a strategic partnership between its subsidiary, Health Gauge, and Lenica Research Group, aimed at enhancing athletic performance through the Peak Cognition platform. The partnership will integrate Health Gauge's advanced health monitoring technology with Lenica's VR-enhanced training tools. The commercial launch is set for July 1, having experienced delays due to the pandemic. The collaboration also targets cognitive training for patients recovering from brain injuries, showcasing a dual focus on both athletic and health market applications.
AI/ML Innovations (CSE:AIML) announces a partnership between its subsidiary Health Gauge and the University of Alberta's ST Innovations to validate data sets for FDA 510k and Health Canada submissions. The collaboration aims to enhance the accuracy of the Phoenix wearable device for monitoring various health metrics. This initiative focuses on refining AI training data through research volunteer monitoring to validate the device's performance compared to conventional methods.
AI/ML Innovations Inc. (CSE:AIML, OTCQB:AIMLF) announced the appointment of Dave Cross as Chief Financial Officer, emphasizing his extensive experience in public accounting. Cross's role is expected to enhance the company's management team as it advances its AI platform commercialization. The company has also engaged Winning Media for strategic digital media services, with a contract worth $250,000 USD for six months. The transition follows the departure of outgoing CFO Vic Hugo, marking a strategic shift in AIML's operational focus.
AI/ML Innovations Inc. has announced that FINRA has approved a change of its stock trading symbol to AIMLF, effective immediately. Previously, the symbol was FIRZF. This change facilitates the trading of the company's shares on the OTCQB Market. AI/ML Innovations is focused on acquiring and advancing technologies utilizing artificial intelligence and machine learning to address urgent societal needs. Its current acquisition strategy emphasizes the digital healthcare sector through its ownership of Health Gauge.
AI/ML Innovations Inc. (CSE:AIML)(OTCQB:AIMLF) has announced that FINRA has approved a change in its stock trading symbol from FIRZF to AIMLF. This change is effective immediately and allows the company's common shares to trade on the OTCQB Market. The company aims to leverage artificial intelligence (AI) and machine learning (ML) technologies, particularly in the digital healthcare sector, where it has acquired a 70% stake in Health Gauge.